AVIRAGEN THERAPEUTICS
Aviragen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening infectious diseases. The Company currently has two Phase 2 clinical-stage product candidates: laninamivir octanoate, which the Company is developing for the treatment of influenza A and B infections in the United States. through a contract with the U.S. Office of Biomedical Advanced Research and Development Authority (BARDA)... that provides up to $231 million in financial support to complete its clinical development; and vapendavir, a potent, oral broad spectrum capsid inhibitor of enteroviruses, including human rhinovirus. In addition to these clinical-stage development programs, the Company has preclinical programs focused on developing treatments for respiratory syncytial virus.
AVIRAGEN THERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
1984-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.aviragentherapeutics.com
Total Employee:
51+
Status:
Active
Contact:
678-221-3343
Email Addresses:
[email protected]
Technology used in webpage:
Microsoft Exchange Online Office 365 Mail IPv6 Google Maps Google Maps API Barracuda Networks Akamai Hosted
Similar Organizations
Ascenta Therapeutics
Ascenta Therapeutics, a clinical-stage biopharmaceutical company, focuses on the discovery and development of new medicines to treat cancer.
Proacta Therapeutics
Proacta Therapeutics is a biopharmaceutical company, engages in the discovery and development of oncology drugs.
SelectX Pharmaceuticals Inc.
SelectX Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery and development of aminoglycoside therapeutics.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-06-03 | Anaconda Pharma | Anaconda Pharma acquired by Aviragen Therapeutics | N/A |
| 2012-04-23 | Nabi Biopharmaceuticals | Nabi Biopharmaceuticals acquired by Aviragen Therapeutics | N/A |
Official Site Inspections
http://www.aviragentherapeutics.com
Unable to get host informations!!!
